199 related articles for article (PubMed ID: 26788345)
1. Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials.
Ondo WG; Hermanowicz N; Borreguero DG; Jaros MJ; Kim R; Shang G
J Clin Mov Disord; 2015; 2():9. PubMed ID: 26788345
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
[TBL] [Abstract][Full Text] [Related]
3. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
Hermanowicz N; Ellenbogen A; Irving G; Buchfuhrer M; Jaros MJ; Shang G; Kim R
CNS Drugs; 2016 May; 30(5):443-54. PubMed ID: 27095237
[TBL] [Abstract][Full Text] [Related]
5. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
[TBL] [Abstract][Full Text] [Related]
7. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
VanMeter SA; Kavanagh ST; Warren S; Barrett RW
CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
[TBL] [Abstract][Full Text] [Related]
8. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
Avidan AY; Lee D; Park M; Jaros MJ; Shang G; Kim R
CNS Drugs; 2016 Apr; 30(4):305-16. PubMed ID: 27067343
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Inoue Y; Hirata K; Uchimura N; Kuroda K; Hattori N; Takeuchi M
Curr Med Res Opin; 2013 Jan; 29(1):13-21. PubMed ID: 23121149
[TBL] [Abstract][Full Text] [Related]
12. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
Winkelman JW; Jaros MJ
Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
[TBL] [Abstract][Full Text] [Related]
13. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin enacarbil: in patients with restless legs syndrome.
Scott LJ
CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
[TBL] [Abstract][Full Text] [Related]
16. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
[TBL] [Abstract][Full Text] [Related]
17. Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment.
Garcia-Borreguero D; Cano-Pumarega I; Garcia Malo C; Cruz Velarde JA; Granizo JJ; Wanner V
Sleep Med; 2019 Mar; 55():74-80. PubMed ID: 30772697
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
Iftikhar IH; Alghothani L; Trotti LM
Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
[TBL] [Abstract][Full Text] [Related]
19. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
